Stocks
Editas Medicine (EDIT) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 3.10 | 3.71 | 3.16 | 1.79 | 1.76 | 1.03 | |||
| Changes by years, y/y, % | +4% | +20% | -15% | -43% | -2% | -10.0% | |||
Editas Medicine. Debt/EBITDA
Editas Medicine. Debt/EBITDA, changes, %
Editas Medicine (EDIT) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| Debt/EBITDA | 1.99 | 1.72 | 1.45 | 1.16 | 1.03 | 1.03 | ||
| Changes by years, y/y, % | -1% | -3% | -11% | -44% | -48% | |||
| Changes by quarters, q/q, % | -4% | -13% | -16% | -20% | -11% | |||
